Kinga Buraczyńska
- Co-authors
- Monika BuraczyńskaAndrzej KsiążekKonrad RejdakJacek KurzepaPiotr KsiążekDavid G. BirchPaul A. SievingDennis R. Hoffman
- Topics
- Advanced Glycation End Products research (4 papers)Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers)Protease and Inhibitor Mechanisms (3 papers)
- Cited by
- NephrologyOphthalmologyBiochemistry
- Partner nations
- PolandUnited StatesChile
In The Last Decade
Kinga Buraczyńska
24 papers receiving 409 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 233
- Cardiology and Cardiovascular Medicine 49
- Genetics 47
- Epidemiology 44
- Immunology 43
Countries citing papers authored by Kinga Buraczyńska
This map shows the geographic impact of Kinga Buraczyńska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kinga Buraczyńska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kinga Buraczyńska more than expected).
Fields of papers citing papers by Kinga Buraczyńska
This network shows the impact of papers produced by Kinga Buraczyńska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kinga Buraczyńska. The network helps show where Kinga Buraczyńska may publish in the future.
Co-authorship network of co-authors of Kinga Buraczyńska
This figure shows the co-authorship network connecting the top 25 collaborators of Kinga Buraczyńska. A scholar is included among the top collaborators of Kinga Buraczyńska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kinga Buraczyńska. Kinga Buraczyńska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 27 | |
| 3 | 6 | |
| 4 | 33 | |
| 5 | 5 | |
| 6 | 16 | |
| 7 | 12 | |
| 8 | 74 | |
| 9 | 18 | |
| 10 | 19 | |
| 11 | 11 | |
| 12 | 9 | |
| 13 | 16 | |
| 14 | 14 | |
| 15 | 10 | |
| 16 | 1 | |
| 17 | 1 | |
| 18 | 9 | |
| 19 | 83 | |
| 20 | 15 |
About Kinga Buraczyńska
Kinga Buraczyńska is a scholar working on Clinical Biochemistry, Biochemistry and Neurology, having authored 24 papers that have together received 414 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers) and Protease and Inhibitor Mechanisms (3 papers). The work is most often cited by research in Nephrology (40 citations), Ophthalmology (40 citations) and Biochemistry (27 citations). Kinga Buraczyńska has collaborated with scholars based in Poland, United States and Chile. Frequent co-authors include Monika Buraczyńska, Andrzej Książek, Konrad Rejdak, Jacek Kurzepa, Piotr Książek, David G. Birch, Paul A. Sieving, Dennis R. Hoffman, Anand Swaroop and Maria A. Musarella. Their work appears in journals such as The American Journal of Human Genetics, Clinical Science and Human Mutation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.